Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 35 Small Cell Lung Carcinoma 34 Leukemia 34 Lung Neoplasms 25 Leukemia, Myeloid, Acute 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, Large B-Cell, Diffuse 19 Neuroblastoma 15 Lymphoma, Non-Hodgkin 15 Carcinoma, Non-Small-Cell Lung 14 Leukemia, Erythroblastic, Acute 13 Hodgkin Disease 13 Leukemia, Myelomonocytic, Acute 12 Leukemia, Monocytic, Acute 12 Leukemia, Megakaryoblastic, Acute 12 Sarcoma 11 Lymphoma, Follicular 10 Burkitt Lymphoma 10 Lymphoma, Large-Cell, Immunoblastic 9 Testicular Neoplasms 7 Teratoma 7 Myelodysplastic Syndromes 7 Congenital Abnormalities 7 Multiple Myeloma 6 Endodermal Sinus Tumor 6 Anemia, Refractory, with Excess of Blasts 6 Testicular Germ Cell Tumor 5 Ovarian Neoplasms 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Central Nervous System Neoplasms 5

Interventions

Oxaliplatin 56 Capecitabine 49 Fluorouracil 37 Cisplatin 37 S 1 (combination) 23 Paclitaxel 18 Docetaxel 18 Leucovorin 16 pembrolizumab 13 Irinotecan 12 apatinib 11 titanium silicide 9 XELOX 9 Trastuzumab 9 Nivolumab 9 Hyperthermic Intraperitoneal Chemotherapy 8 Epirubicin 8 Drug Therapy 8 Tegafur 7 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Surgical Procedures, Operative 5 Gastrectomy 5 Chemotherapy, Adjuvant 5 tislelizumab 4 S-1 plus cisplatin 4 Ramucirumab 4 zolbetuximab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × Etoposide × Clear all

NCT02338518 2023-09-29

SVOSA

Jinling Hospital, China

Phase 3 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡